Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report

被引：0
|
作者：
Bai-Yan Wang
Wan-Hong Zhao
Yin-Xia Chen
Xing-Mei Cao
Yun Yang
Yi-Lin Zhang
Fang-Xia Wang
Peng-Yu Zhang
Bo Lei
Liu-Fang Gu
Jian-Li Wang
Ju Bai
Yan Xu
Xu-Geng Wang
Rui-Li Zhang
Li-Li Wei
Qiu-Chuan Zhuang
Frank Fan
Wang-Gang Zhang
Ai-Li He
Jie Liu
机构：
[1] The Second Affiliated Hospital of Xi’an Jiaotong University,Department of Hematology
[2] The Second Affiliated Hospital of Xi’an Jiaotong University,Department of Hematology and National
[3] Nanjing Legend Biotech,Local Joint Engineering Research Center of Biodiagnostics & Biotherapy
[4] The Second Affiliated Hospital of Xi’an Jiaotong University,undefined
来源：
Journal of Medical Case Reports | / 16卷
关键词：
Multiple myeloma; CAR-T; BCMA; Case study; Extramedullary disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 14 条
  • [1] Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report
    Wang, Bai-Yan
    Zhao, Wan-Hong
    Chen, Yin-Xia
    Cao, Xing-Mei
    Yang, Yun
    Zhang, Yi-Lin
    Wang, Fang-Xia
    Zhang, Peng-Yu
    Lei, Bo
    Gu, Liu-Fang
    Wang, Jian-Li
    Bai, Ju
    Xu, Yan
    Wang, Xu-Geng
    Zhang, Rui-Li
    Wei, Li-Li
    Zhuang, Qiu-Chuan
    Fan, Frank
    Zhang, Wang-Gang
    He, Ai-Li
    Liu, Jie
    JOURNAL OF MEDICAL CASE REPORTS, 2022, 16 (01)
  • [2] Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial
    Xu, Jie
    Wang, Bai-Yan
    Yu, Shan-He
    Chen, Shi-Jun
    Yang, Shuang-Shuang
    Liu, Rui
    Chen, Li-Juan
    Hou, Jian
    Chen, Zhu
    Zhao, Wan-Hong
    He, Ai-Li
    Mi, Jian-Qing
    Chen, Sai-Juan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [3] Preclinical assessment of LCAR-B38M, a novel BCMA-targeting chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory multiple myeloma
    Fan, Xiaohu
    Zhuang, Qiuchuan
    Yang, Lei
    Hao, Jiaying
    Zhao, Dan
    Zhao, Yuncheng
    Wang, Pingyan
    Geng, Dong
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E160 - E160
  • [4] A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
    Wan-Hong Zhao
    Jie Liu
    Bai-Yan Wang
    Yin-Xia Chen
    Xing-Mei Cao
    Yun Yang
    Yi-Lin Zhang
    Fang-Xia Wang
    Peng-Yu Zhang
    Bo Lei
    Liu-Fang Gu
    Jian-Li Wang
    Nan Yang
    Ru Zhang
    Hui Zhang
    Ying Shen
    Ju Bai
    Yan Xu
    Xu-Geng Wang
    Rui-Li Zhang
    Li-Li Wei
    Zong-Fang Li
    Zhen-Zhen Li
    Yan Geng
    Qian He
    Qiu-Chuan Zhuang
    Xiao-Hu Fan
    Ai-Li He
    Wang-Gang Zhang
    Journal of Hematology & Oncology, 11
  • [5] A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
    Zhao, Wan-Hong
    Liu, Jie
    Wang, Bai-Yan
    Chen, Yin-Xia
    Cao, Xing-Mei
    Yang, Yun
    Zhang, Yi-Lin
    Wang, Fang-Xia
    Zhang, Peng-Yu
    Lei, Bo
    Gu, Liu-Fang
    Wang, Jian-Li
    Yang, Nan
    Zhang, Ru
    Zhang, Hui
    Shen, Ying
    Xu, Ju Bai Yan
    Wang, Xu-Geng
    Zhang, Rui-Li
    Wei, Li-Li
    Li, Zong-Fang
    Li, Zhen-Zhen
    Geng, Yan
    He, Qian
    Zhuang, Qiu-Chuan
    Fan, Xiao-Hu
    He, Ai-Li
    Zhang, Wang-Gang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [6] Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)
    Zhao, Wan-Hong
    Wang, Bai-Yan
    Chen, Li-Juan
    Fu, Wei-Jun
    Xu, Jie
    Liu, Jie
    Jin, Shi-Wei
    Chen, Yin-Xia
    Cao, Xing-Mei
    Yang, Yun
    Zhang, Yi-Lin
    Wang, Fang-Xia
    Zhang, Peng-Yu
    Lei, Bo
    Gu, Liu-Fang
    Wang, Jian-Li
    Zhang, Hui
    Bai, Ju
    Xu, Yan
    Zhu, Han
    Du, Juan
    Jiang, Hua
    Fan, Xiao-Hu
    Li, Jian-Yong
    Hou, Jian
    Chen, Zhu
    Zhang, Wang-Gang
    Mi, Jian-Qing
    Chen, Sai-Juan
    He, Ai-Li
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [7] Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)
    Wan-Hong Zhao
    Bai-Yan Wang
    Li-Juan Chen
    Wei-Jun Fu
    Jie Xu
    Jie Liu
    Shi-Wei Jin
    Yin-Xia Chen
    Xing-Mei Cao
    Yun Yang
    Yi-Lin Zhang
    Fang-Xia Wang
    Peng-Yu Zhang
    Bo Lei
    Liu-Fang Gu
    Jian-Li Wang
    Hui Zhang
    Ju Bai
    Yan Xu
    Han Zhu
    Juan Du
    Hua Jiang
    Xiao-Hu Fan
    Jian-Yong Li
    Jian Hou
    Zhu Chen
    Wang-Gang Zhang
    Jian-Qing Mi
    Sai-Juan Chen
    Ai-Li He
    Journal of Hematology & Oncology, 15
  • [8] A Potential Terminator of Multiple Myeloma: Myeloma: LCAR-B38M CAR-T Cells Achieved Unprecedented High Rate of Continuous Complete Remission (CCR) in Refractory or Relapsed Multiple Myeloma Patients
    Fan, Frank
    Zhao, Wanhong
    Liu, Jie
    He, Aili
    Chen, Yinxia
    Cao, Xingmei
    Yang, Nan
    Wang, Baiyan
    Zhang, Pengyu
    Zhang, Yilin
    Wang, Fangxia
    Lei, Bo
    Gu, Liufang
    Wang, Xugeng
    Zhuang, Qiuchuan
    Zhang, Wanggang
    MOLECULAR THERAPY, 2017, 25 (05) : 334 - 334
  • [9] Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma
    Zhao, Wan-Hong
    Liu, Jie
    Wang, Bai-Yan
    Chen, Yin-Xia
    Cao, Xing-Mei
    Yang, Yun
    Zhang, Yi-Lin
    Wang, Fang-Xia
    Zhang, Peng-Yu
    Lei, Bo
    Gu, Liu-Fang
    Wang, Jian-Li
    Yang, Nan
    Zhang, Ru
    Zhang, Hui
    Shen, Ying
    Bai, Ju
    Xu, Yan
    Wang, Xu-Geng
    Zhang, Rui-Li
    Wei, Li-Li
    Li, Zong-Fang
    Li, Zhen-Zhen
    Geng, Yan
    He, Qian
    Zhuang, Qiu-Chuan
    Fan, Frank Xiao-Hu
    He, Ai-Li
    Zhang, Wang-Gang
    BLOOD, 2018, 132
  • [10] Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment of LCAR-B38M CAR-T: At least 5-year follow-up in LEGEND-2.
    Mi, Jian-Qing
    Zhao, Wan-Hong
    Chen, Li-Juan
    Fu, Wei-Jun
    Wang, Bai-Yan
    Xu, Jie
    Liu, Jie
    Jin, Shi-Wei
    Zhu, Han
    Du, Juan
    Jiang, Hua
    Sun, Huabin
    Jia, Yehui
    Fan, Xiao-Hu
    Li, Jian-Yong
    Hou, Jian
    Chen, Zhu
    Zhang, Wang-Gang
    He, Ai-Li
    Chen, Sai-Juan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12